Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill S Dolinsky

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|November 4, 2020
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast CancerSiddhartha Yadav, Holly LaDuca, Eric C Polley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 1, 2017
Somatic TP53 variants frequently confound germ-line testing resultsJeffrey N Weitzel, Elizabeth C Chao, Bita Nehoray, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2019
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsHolly LaDuca, Eric C Polley, Amal Yussuf, et al.
JAMA Network Open|October 24, 2019
Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary CancerRachid Karam, Blair Conner, Holly LaDuca, et al.
Nature Communications|April 1, 2025
A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associationsAnton Safonov, Tomoki T Nomakuchi, Elizabeth Chao, et al.
Journal of the National Cancer Institute|August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel TestingHermela Shimelis, Holly LaDuca, Chunling Hu, et al.
JCO Oncology Practice|September 21, 2023
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled TrialHuma Q Rana, Jill E Stopfer, Michelle Weitz, et al.
Cancer Research|July 18, 2020
A Rare <i>TP53</i> Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple CancersJacquelyn Powers, Emilia M Pinto, Thibaut Barnoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2021
Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the BreastSiddhartha Yadav, Chunling Hu, Katherine L Nathanson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the BreastHuaizhi Huang, Ronan E Couch, Rachid Karam, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|November 4, 2020
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast CancerSiddhartha Yadav, Holly LaDuca, Eric C Polley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 1, 2017
Somatic TP53 variants frequently confound germ-line testing resultsJeffrey N Weitzel, Elizabeth C Chao, Bita Nehoray, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2019
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsHolly LaDuca, Eric C Polley, Amal Yussuf, et al.
JAMA Network Open|October 24, 2019
Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary CancerRachid Karam, Blair Conner, Holly LaDuca, et al.
Nature Communications|April 1, 2025
A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associationsAnton Safonov, Tomoki T Nomakuchi, Elizabeth Chao, et al.
Journal of the National Cancer Institute|August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel TestingHermela Shimelis, Holly LaDuca, Chunling Hu, et al.
JCO Oncology Practice|September 21, 2023
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled TrialHuma Q Rana, Jill E Stopfer, Michelle Weitz, et al.
Cancer Research|July 18, 2020
A Rare <i>TP53</i> Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple CancersJacquelyn Powers, Emilia M Pinto, Thibaut Barnoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2021
Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the BreastSiddhartha Yadav, Chunling Hu, Katherine L Nathanson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the BreastHuaizhi Huang, Ronan E Couch, Rachid Karam, et al.
Pageof 4